BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 17849811)

  • 21. Sex hormones and the cardiovascular system: effects on arterial function in women.
    Teede HJ
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):672-6. PubMed ID: 17581228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Quantitative evaluation of the cardiovascular risk associated with hormone substitution therapy during menopause].
    Scarabin PY; Plu-Bureau G
    Arch Mal Coeur Vaiss; 1993 Feb; 86(2):243-8. PubMed ID: 8363427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis.
    Atsma F; Bartelink ML; Grobbee DE; van der Schouw YT
    Menopause; 2006; 13(2):265-79. PubMed ID: 16645540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HRT and the primary prevention of cardiovascular disease.
    Stevenson JC
    Maturitas; 2007 May; 57(1):31-4. PubMed ID: 17383835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardiovascular risk after menopause].
    Grand A
    Ann Cardiol Angeiol (Paris); 1992 Mar; 41(3):151-61. PubMed ID: 1610097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular disease after menopause: a growing epidemic.
    Alexander J; Clearfield M
    Minerva Ginecol; 2006 Feb; 58(1):35-40. PubMed ID: 16498369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular protection by estrogen: a hemodynamic mechanism?
    Rozenberg S; Liebens I; Vandromme J; Hotimsky A; Van Rijsselberge M
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 1():36-42. PubMed ID: 8199639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone therapy and cardiovascular disease--still much to be learnt.
    Mikkola TS; Ylikorkala O
    Gynecol Endocrinol; 2005 Feb; 20(2):116-20. PubMed ID: 15823832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
    Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Should all menopausal women have hormone replacement therapy for the prevention of coronary disease?].
    Neves-e-Castro M
    Rev Port Cardiol; 1999 Nov; 18(11):1039-43. PubMed ID: 10608164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atherosclerosis and estrogen replacement therapy.
    Sullivan JM
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 1():28-35. PubMed ID: 8199638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypertension and menopause].
    Masszi G
    Orv Hetil; 2002 Dec; 143(51):2821-8. PubMed ID: 12638308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Menopause and cardiovascular disease: the evidence.
    Rosano GM; Vitale C; Marazzi G; Volterrani M
    Climacteric; 2007 Feb; 10 Suppl 1():19-24. PubMed ID: 17364594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postmenopausal hormone therapy and cardiovascular disease: an overview of main findings.
    Canonico M; Straczek C; Oger E; Plu-Bureau G; Scarabin PY
    Maturitas; 2006 Jul; 54(4):372-9. PubMed ID: 16730142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary heart disease in menopausal women: implications of primary and secondary prevention trials of hormones.
    Rossouw JE
    Maturitas; 2005 May; 51(1):51-63. PubMed ID: 15883110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women.
    Maturana MA; Breda V; Lhullier F; Spritzer PM
    Metabolism; 2008 Jul; 57(7):961-5. PubMed ID: 18555838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing cardiovascular risk in menopausal women.
    Rosano GM; Vitale C; Tulli A
    Climacteric; 2006 Sep; 9 Suppl 1():19-27. PubMed ID: 16899440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease].
    Kozakiewicz K; Wycisk A
    Wiad Lek; 2006; 59(5-6):377-82. PubMed ID: 17017486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevention of cardiovascular risk in menopause women: role of ovarian hormones].
    Rosano GM; Leonardo F; Ricci S; Serra GB; Chierchia SL
    Ann Ist Super Sanita; 1997; 33(2):199-202. PubMed ID: 9470240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.